Multiple Rising Does Study (Subcutaneous Doses) of BI 655064 in Male and Female Patients With Chronic Primary Immune Thrombocytopenic Purpura (ITP).
Last updated on April 2022Recruitment
- Recruitment Status
- Terminated
- Estimated Enrollment
- 10
Summary
- Conditions
- Purpura, Thrombocytopenic, Idiopathic
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: N/A
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Tracking Information
- NCT #
- NCT02009761
- Collaborators
- Not Provided
- Investigators
- Study Chair: Boehringer Ingelheim Boehringer Ingelheim
Get Well Soon